Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 480

1.

Postoperative residua and sequelae in adults with repaired tetralogy of Fallot.

Masuda M.

Gen Thorac Cardiovasc Surg. 2016 Apr 26. [Epub ahead of print] Review.

PMID:
27116601
2.

SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?

Sattar N, McLaren J, Kristensen SL, Preiss D, McMurray JJ.

Diabetologia. 2016 Apr 25. [Epub ahead of print] Review.

PMID:
27112340
3.

Pharmacological and Endovascular Reversal of Left Ventricular Remodeling.

Jaiswal A, Nguyen VQ, Carry BJ, Le Jemtel TH.

J Card Fail. 2016 Apr 19. pii: S1071-9164(16)30010-0. doi: 10.1016/j.cardfail.2016.03.017. [Epub ahead of print] Review.

PMID:
27109620
4.

Assessment and impact of diastolic function by echocardiography in elderly patients.

Dugo C, Rigolli M, Rossi A, Whalley GA.

J Geriatr Cardiol. 2016 Mar;13(3):252-60. doi: 10.11909/j.issn.1671-5411.2016.03.008. Review.

5.

Neprilysin inhibition with sacubitril/valsartan in the treatment of heart failure: mortality bang for your buck.

Ansara AJ, Kolanczyk DM, Koehler JM.

J Clin Pharm Ther. 2016 Apr;41(2):119-27. doi: 10.1111/jcpt.12363. Epub 2016 Mar 18. Review.

PMID:
26992459
6.

Defining Advanced Heart Failure: A Systematic Review of Criteria Used in Clinical Trials.

Bjork JB, Alton KK, Georgiopoulou VV, Butler J, Kalogeropoulos AP.

J Card Fail. 2016 Mar 11. pii: S1071-9164(16)00076-2. doi: 10.1016/j.cardfail.2016.03.003. [Epub ahead of print] Review.

PMID:
26975942
7.

Novel device-based interventional strategies for advanced heart failure.

Toth GG, Vanderheyden M, Bartunek J.

Postepy Kardiol Interwencyjnej. 2016;12(1):13-6. doi: 10.5114/pwki.2016.56944. Epub 2016 Feb 11. Review.

8.

The clinical dilemma of heart failure with preserved ejection fraction: an update on pathophysiology and management for physicians.

Irizarry Pagán EE, Vargas PE, López-Candales A.

Postgrad Med J. 2016 Mar 10. pii: postgradmedj-2015-133859. doi: 10.1136/postgradmedj-2015-133859. [Epub ahead of print] Review.

PMID:
26964562
9.

Timeline of History of Hypertension Treatment.

Saklayen MG, Deshpande NV.

Front Cardiovasc Med. 2016 Feb 23;3:3. doi: 10.3389/fcvm.2016.00003. eCollection 2016. Review.

10.

Animal models of heart failure with preserved ejection fraction.

Conceição G, Heinonen I, Lourenço AP, Duncker DJ, Falcão-Pires I.

Neth Heart J. 2016 Apr;24(4):275-86. doi: 10.1007/s12471-016-0815-9. Review.

11.

Update on ivabradine for heart failure.

Borer JS, Tavazzi L.

Trends Cardiovasc Med. 2016 Jan 28. pii: S1050-1738(16)00022-0. doi: 10.1016/j.tcm.2016.01.004. [Epub ahead of print] Review.

PMID:
26934996
12.

Is enhancing cGMP-PKG signalling a promising therapeutic target for heart failure with preserved ejection fraction?

Kovács Á, Alogna A, Post H, Hamdani N.

Neth Heart J. 2016 Apr;24(4):268-74. doi: 10.1007/s12471-016-0814-x. Epub 2016 Feb 29. Review.

13.

How to diagnose heart failure with preserved ejection fraction: the value of invasive stress testing.

Huis In 't Veld AE, de Man FS, van Rossum AC, Handoko ML.

Neth Heart J. 2016 Apr;24(4):244-51. doi: 10.1007/s12471-016-0811-0. Review.

14.

Understanding heart failure with preserved ejection fraction: where are we today?

van Heerebeek L, Paulus WJ.

Neth Heart J. 2016 Apr;24(4):227-36. doi: 10.1007/s12471-016-0810-1. Review.

15.

"Nihilism" of chronic heart failure therapy in children and why effective therapy is withheld.

Schranz D, Voelkel NF.

Eur J Pediatr. 2016 Apr;175(4):445-55. doi: 10.1007/s00431-016-2700-3. Epub 2016 Feb 19. Review.

16.

[Biochemical predictors of anthracyclin and trastuzumab induced cardiotoxicity in early diagnostics of cardiomyopathy].

Słowik A, Lelakowska-Pieła M, Konduracka E.

Pol Merkur Lekarski. 2016 Jan;40(235):40-5. Review. Polish.

PMID:
26891436
17.

The role of titin and extracellular matrix remodelling in heart failure with preserved ejection fraction.

Franssen C, González Miqueo A.

Neth Heart J. 2016 Apr;24(4):259-67. doi: 10.1007/s12471-016-0812-z. Review.

18.

Evolving Concepts of Pulmonary Hypertension Secondary to Left Heart Disease.

Ramu B, Thenappan T.

Curr Heart Fail Rep. 2016 Apr;13(2):92-102. doi: 10.1007/s11897-016-0284-x. Review.

PMID:
26886381
19.

Management of asymptomatic (occult) feline cardiomyopathy: Challenges and realities.

Fox PR, Schober KA.

J Vet Cardiol. 2015 Dec;17 Suppl 1:S150-8. doi: 10.1016/j.jvc.2015.03.004. Review.

PMID:
26776574
20.

Echocardiographic evaluation of left ventricular diastolic function in cats: Hemodynamic determinants and pattern recognition.

Schober KE, Chetboul V.

J Vet Cardiol. 2015 Dec;17 Suppl 1:S102-33. doi: 10.1016/j.jvc.2015.02.002. Review.

PMID:
26776572
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk